BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home » Authors » Jim Stommen

Articles by Jim Stommen

Regulatory concerns are a focal point for investors, innovators

July 1, 2010
By Jim Stommen

Unfortunate reality for millions worldwide means players in the obesity space have room to grow

July 1, 2010
By Jim Stommen

Wading in regulatory waters with Schultz, Leahey and Ubl

May 28, 2010
By Jim Stommen

Docs weigh in on outlook for innovation & medical practice

May 27, 2010
By Jim Stommen

In a challenging environment, the top-quality deals get done

May 26, 2010
By Jim Stommen
MINNEAPOLIS – With the initial public offering (IPO) window essentially nailed shut over the past two-plus years, corporate buyers have held the keys to the exit for venture-backed companies. (Medical Device Daily)
Read More

Regulatory path uncertainty a big-time concern for VCs

May 25, 2010
By Jim Stommen
MINNEAPOLIS – If you want to know about the state of healthcare investing, who better to ask than those who pull the trigger, or maybe don't? (Medical Device Daily)
Read More

Investment dollars down, but interest in sector is strong

May 24, 2010
By Jim Stommen
MINNEAPOLIS – Going by the numbers, it's true that investing in medical technology is down, a status shared by virtually all sectors after the economic meltdown of the past couple of years. But another set of numbers clearly indicates that interest in med-tech investing continues to be strong. (Medical Device Daily)
Read More

Attention to regulatory, reimbursement pathways shows growing concerns

March 1, 2010
By Jim Stommen

Attention to regulatory, reimbursement pathways shows growing concerns

March 1, 2010
By Jim Stommen

Medical entrepreneur Bill Cook worries about sector's future

Dec. 9, 2009
By Jim Stommen
Bill Cook is pretty blunt when it comes to predicting the potential impact of the so-called "device tax" being mulled as part of the ongoing congressional discussion on healthcare reform. Add to that impact the growing costs of meeting regulatory requirements and the picture for both medical product start-ups and established companies is murky at best. (Medical Device Daily)
Read More
Previous 1 2 … 10 11 12 13 14 15 16 17 18 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 30, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing